Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma

Lin Wang; Chuanhao Tang; Bin Xu; Lin Yang; Lili Qu; Liangliang Li; Xiaoyan Li; Weixia Wang; Haifeng Qin; Hongjun Gao; Kun He; Xiaoqing Liu

doi:10.1371/journal.pone.0179000

Loading metrics

Open Access

Peer-reviewed

Research Article

Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma

Lin Wang,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Chuanhao Tang,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Bin Xu,

Affiliation National Center of Biomedical Analysis, Beijing, China
⨯
Lin Yang,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Lili Qu,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Liangliang Li,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Xiaoyan Li,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Weixia Wang,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Haifeng Qin,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Hongjun Gao,

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
⨯
Kun He,

Affiliation National Center of Biomedical Analysis, Beijing, China
⨯
Xiaoqing Liu

* E-mail: liuxq@medmail.com.cn

Affiliation Department of Lung Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China

http://orcid.org/0000-0001-7303-5309

⨯

Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma

Lin Wang,
Chuanhao Tang,
Bin Xu,
Lin Yang,
Lili Qu,
Liangliang Li,
Xiaoyan Li,
Weixia Wang,
Haifeng Qin,
Hongjun Gao

Published: June 8, 2017
https://doi.org/10.1371/journal.pone.0179000

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Biomarkers
Is the Subject Area "Biomarkers" applicable to this article?

Thanks for your feedback.
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry
Is the Subject Area "Matrix-assisted laser desorption ionization time-of-flight mass spectrometry" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Adenocarcinoma
Is the Subject Area "Adenocarcinoma" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Adenocarcinoma of the lung
Is the Subject Area "Adenocarcinoma of the lung" applicable to this article?

Thanks for your feedback.
Forecasting
Is the Subject Area "Forecasting" applicable to this article?

Thanks for your feedback.